Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree.
Saved in:
| Title: | Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. |
|---|---|
| Authors: | Hendley AM; Diabetes Center, University of California, San Francisco, San Francisco, United States.; Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, San Francisco, United States., Rao AA; CoLabs, University of California, San Francisco, San Francisco, United States.; Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, United States., Leonhardt L; Diabetes Center, University of California, San Francisco, San Francisco, United States., Ashe S; Diabetes Center, University of California, San Francisco, San Francisco, United States., Smith JA; Diabetes Center, University of California, San Francisco, San Francisco, United States., Giacometti S; Diabetes Center, University of California, San Francisco, San Francisco, United States., Peng XL; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, United States., Jiang H; Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States., Berrios DI; Diabetes Center, University of California, San Francisco, San Francisco, United States., Pawlak M; Evergrande Center for Immunologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, United States., Li LY; Diabetes Center, University of California, San Francisco, San Francisco, United States., Lee J; Diabetes Center, University of California, San Francisco, San Francisco, United States., Collisson EA; Division of Hematology and Oncology, Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States., Anderson MS; Diabetes Center, University of California, San Francisco, San Francisco, United States., Fragiadakis GK; CoLabs, University of California, San Francisco, San Francisco, United States.; Bakar ImmunoX Initiative, University of California, San Francisco, San Francisco, United States.; Department of Medicine, Division of Rheumatology, University of California, San Francisco, San Francisco, United States., Yeh JJ; Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, United States., Ye CJ; Parker Institute for Cancer Immunotherapy, San Francisco, United States., Kim GE; Department of Pathology, University of California, San Francisco, San Francisco, United States., Weaver VM; Center for Bioengineering and Tissue Regeneration, University of California, San Francisco, San Francisco, United States., Hebrok M; Diabetes Center, University of California, San Francisco, San Francisco, United States. |
| Source: | ELife [Elife] 2021 May 19; Vol. 10. Date of Electronic Publication: 2021 May 19. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
